1-3 of 3
Kerry Dillingham
Close
Sort by
Journal Articles

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice – Interim Results From a Large, European, Observational Study

Dominik Selleslag, Ann Janssens, Hans Wadenvik, Michael Steurer, MD, Philippe Quittet, MD, Georgia Kaiafa, Tomas Kozak, MD, Helen Papadaki, Jean-François Viallard, MD, PhD, Kerry Dillingham, Georg Kreuzbauer, MD
Journal: Blood
Blood (2012) 120 (21): 3316.
https://doi.org/10.1182/blood.V120.21.3316.3316
Published: 2012
Journal Articles

Romiplostim for the Treatment of Adults with Primary Immune Thrombocytopenia (ITP) in Routine Clinical Practice in France – Interim Results From a Large Observational Study

Philippe Quittet, MD, Mohamed Hamidou, Bernard Bonnotte, M.D., Ph.D., Olivier Fain, Kerry Dillingham, Georg Kreuzbauer, MD
Journal: Blood
Blood (2012) 120 (21): 4643.
https://doi.org/10.1182/blood.V120.21.4643.4643
Published: 2012
Journal Articles

Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP),

Ann Janssens, MD, Michael D. Tarantino, MD, Robert Bird, MD, Maria Gabriella Mazzucconi, MD, Ralph Vincent V. Boccia, MD, Maria Fernanda Lopez-Fernandez, MD, Tomas Kozak, MD, Michael Steurer, MD, Peter A.W. Te Boekhorst, MD, PhD, Kerry Dillingham, MSc, Richard Lizambri, MD
Journal: Blood
Blood (2011) 118 (21): 3279.
https://doi.org/10.1182/blood.V118.21.3279.3279
Published: 2011